RecruitingNCT06265363

Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants With a BW >1500 Grs or GA ≥33 Wks in Turkey.

Evaluation of the Frequency of Retinopathy of Prematurity, Influencing Risk Factors, and Treatment Outcomes in Premature Infants With a Birth Weight >1500 Grams or Gestational Age ≥33 Weeks in Turkey.

Sponsor

Baskent University Ankara Hospital

Enrollment

1,000 participants

Start Date

Aug 1, 2023

Study Type

OBSERVATIONAL

Conditions

Retinopathy of Prematurity

Summary

The study includes preterm infants who are being screened for ROP between August 1,2023 and August 1, 2024 in 94 neonatal intensive care units (NICUs) in Turkey. Infants with birth weight (BW) of \>1500 g or ≥ 33 weeks' gestation who are screened for retinopathy of prematurity are included. The incidence of any ROP, severe ROP and treatment modalities will be determined. The risk factors for ROP development will also be evaluated.

Eligibility

Min Age: 28 Days

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with retinopathy of prematurity. The study is currently recruiting participants at 1 location. People eligible for this study include aged 28 Days and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.